Research Correspondence

Who to contact and why

This desk welcomes correspondence from researchers, writers, and careful readers. The most useful messages are those pointing to a more recent publication than a source we have cited, flagging a factual error in the text, or noting a regulatory change that updates the status of a compound covered here.

We do not provide individualized research consultation, dosing guidance, compound sourcing recommendations, or medical advice of any kind. We cannot recommend suppliers, clinics, practitioners, or products — that is outside the editorial scope of this site. Messages of that type will not receive a reply.

For all editorial correspondence: editorial@peptidespodcast.com

A note on response time

This is a small editorial desk. Response times vary. Priority is given to messages concerning factual errors or outdated citations — those are the ones that matter most to the accuracy of the record and will receive the fastest attention.

If you are a journalist or researcher writing about research peptides and would like to discuss the published evidence on a compound covered here, please include enough context in your message for us to understand what you are working on. We are happy to discuss what the literature shows.